Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
44.07
-2.79 (-5.95%)
At close: Jan 30, 2026, 4:00 PM EST
43.82
-0.25 (-0.57%)
After-hours: Jan 30, 2026, 7:59 PM EST
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
$384,828
Profits / Employee
-$537,241
Market Cap
17.22B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Genmab | 2,681 |
| Incyte | 2,617 |
| Exelixis | 1,147 |
| Ionis Pharmaceuticals | 1,069 |
| Ascendis Pharma | 1,017 |
| Revolution Medicines | 809 |
| Roivant Sciences | 750 |
| BridgeBio Pharma | 730 |
MRNA News
- 14 hours ago - Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? - Seeking Alpha
- 15 hours ago - Moderna CMO Jacqueline Miller to step down - Reuters
- 17 hours ago - Dr. David Berman to Join Moderna as Chief Development Officer - Accesswire
- 1 day ago - RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA - GlobeNewsWire
- 1 day ago - Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) - Accesswire
- 4 days ago - Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026 - Accesswire
- 8 days ago - MRNY: Jumping On Big Moderna Move - Seeking Alpha
- 8 days ago - Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV - Reuters